Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary


Jazz Pharmaceuticals is owned by 91.89% institutional investors, 2.95% insiders, and 5.16% retail investors. Vanguard group is the largest institutional shareholder, holding 10.11% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.38% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals91.89%2.95%5.16%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustryBiotech Stocks 44.85%7.67%47.48%
IdeaCannabis Stocks List21.30%7.65%71.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group6.32M10.11%$674.82M
Blackrock6.15M9.83%$655.94M
Lsv asset management2.48M3.97%$264.75M
Capital world investors2.02M3.23%$215.55M
State street2.02M3.23%$215.31M
Pacer advisors1.82M2.91%$194.35M
Jpmorgan chase1.54M2.46%$164.19M
Vestal point capital, lp1.50M2.40%$160.09M
Ameriprise financial1.46M2.34%$155.97M
Polaris capital management1.38M2.20%$146.80M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vestal point capital, lp1.50M11.94%$160.09M
Estuary capital management lp267.44K9.20%$28.54M
Polaris capital management1.38M7.87%$146.80M
Krensavage asset management109.08K5.35%$11.64M
Baupost group llc/ma1.27M3.74%$136.00M
Camber capital management lp1.15M3.40%$122.74M
Ecor1 capital1.01M3.31%$108.22M
Avidity partners management lp544.50K2.47%$58.11M
Graphene investments sas31.40K2.11%$3.35M
Fairbanks capital management27.11K1.90%$2.89M

Top Buyers

HolderShares% AssetsChange
Swedbank ab1.00M0.14%1.00M
Rubric capital management lp616.62K1.73%616.62K
Capital world investors2.02M0.04%591.71K
Pacer advisors1.82M0.44%527.19K
Baupost group llc/ma1.27M3.74%440.55K

Top Sellers

HolderShares% AssetsChange
Blackrock6.15M0.01%-924.16K
Fuller & thaler asset management469.67K0.21%-615.47K
State street2.02M0.01%-444.83K
Pictet asset management sa238.92K0.03%-308.83K
Morgan stanley715.62K0.01%-243.49K

New Positions

HolderShares% AssetsChangeValue
Swedbank ab1.00M0.14%1.00M$106.94M
Rubric capital management lp616.62K1.73%616.62K$65.81M
Tang capital management140.00K1.52%140.00K$14.94M
Distillate capital partners131.42K0.74%131.42K$14.03M
Susquehanna fundamental investments106.75K0.26%106.75K$11.39M

Sold Out

HolderChange
Center for financial planning-1.00
Financial gravity asset management-2.00
Advisornet financial-2.00
Rfp financial group-2.00
Householder group estate & retirement specialist-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024456-6.37%57,467,965-0.65%911.10%218-6.84%1620.62%
Mar 31, 2024487-4.32%57,846,6723.04%911.16%234-0.85%161-10.56%
Dec 31, 20235093.25%56,141,8891.42%881.19%2367.76%1800.56%
Sep 30, 20234933.14%55,355,905-0.53%861.13%2197.88%1797.83%
Jun 30, 20234780.63%55,648,516-1.09%871.12%203-8.97%1667.10%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.09M3.38%-1.19K
iShares Core S&P Mid-Cap ETF1.94M3.22%1.06K
Vanguard Total Stock Mkt Idx Inv1.84M2.98%-44.10K
American Funds Fundamental Invs A1.80M2.91%-199.74K
Capital Group Fundamental Invtrs Comp1.80M2.91%-199.74K
Vanguard Small Cap Index1.47M2.38%-46.00K
Vanguard Small Cap Value Index Inv994.37K1.61%-22.04K
Vanguard Institutional Extnd Mkt Idx Tr924.75K1.50%-39.85K
JPM US Mid Cap Value-MA855.85K1.39%-
JPM US Mid Cap Value-Composite855.85K1.39%-9.39K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 01, 2024COZADD BRUCE C Chairman & CEOSell$110.84K
Sep 06, 2024Henderson Mary Elizabeth SVP, Technical OperationsSell$152.70K
Jun 07, 2024Carr Patricia SVP, Chief Accounting OfficerSell$17.74K
May 03, 2024Patil Neena M EVP & Chief Legal OfficerSell$548.25K
Mar 06, 2024Carr Patricia SVP, Chief Accounting OfficerSell$82.26K

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2-2
2024 Q113
2023 Q4-2
2023 Q3-14

JAZZ Ownership FAQ


Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 91.89%, followed by 2.95% insiders and 5.16% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 44.85%, which Jazz Pharmaceuticals exceeds.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Vanguard group (6.32M shares, 10.11%), Blackrock (6.15M shares, 9.83%), and Lsv asset management (2.48M shares, 3.97%). Together, they hold 23.90% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Vestal point capital, lp is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.94% of its assets in 1.5M Jazz Pharmaceuticals shares, valued at 160.1M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.38% of its total shares outstanding invested in 2.09M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools